Maravai LifeSciences Holdings Future Growth
Future criteria checks 4/6
Maravai LifeSciences Holdings is forecast to grow earnings and revenue by 126.7% and 8.3% per annum respectively. EPS is expected to grow by 117.4% per annum. Return on equity is forecast to be 2.4% in 3 years.
Key information
126.7%
Earnings growth rate
117.4%
EPS growth rate
| Life Sciences earnings growth | 16.5% |
| Revenue growth rate | 8.3% |
| Future return on equity | 2.4% |
| Analyst coverage | Good |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price Could Signal Some Risk
Dec 02Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 26% Below Its Share Price
Oct 07Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Worth US$41.7 Based On Its Intrinsic Value?
Jul 01Maravai LifeSciences: The Future Beyond Covid Vaccines
Jun 29Need To Know: Analysts Are Much More Bullish On Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
May 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 346 | 6 | 102 | 120 | 7 |
| 12/31/2025 | 301 | -2 | 71 | 94 | 13 |
| 12/31/2024 | 272 | -13 | 44 | 64 | 13 |
| 12/31/2023 | 289 | -119 | 61 | 126 | N/A |
| 9/30/2023 | 420 | 25 | 163 | 218 | N/A |
| 6/30/2023 | 544 | 75 | 268 | 314 | N/A |
| 3/31/2023 | 718 | 153 | 437 | 459 | N/A |
| 12/31/2022 | 883 | 220 | 519 | 536 | N/A |
| 9/30/2022 | 907 | 238 | 479 | 495 | N/A |
| 6/30/2022 | 920 | 248 | 479 | 491 | N/A |
| 3/31/2022 | 895 | 226 | 478 | 493 | N/A |
| 12/31/2021 | 799 | 182 | 354 | 369 | N/A |
| 9/30/2021 | 669 | 150 | 371 | 389 | N/A |
| 6/30/2021 | 552 | 127 | 308 | 335 | N/A |
| 3/31/2021 | 381 | 78 | 155 | 181 | N/A |
| 12/31/2020 | 284 | 77 | 127 | 152 | N/A |
| 12/31/2019 | 143 | -8 | 7 | 24 | N/A |
| 12/31/2018 | 124 | -18 | -4 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MRVI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: MRVI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MRVI is expected to become profitable in the next 3 years.
Revenue vs Market: MRVI's revenue (8.3% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: MRVI's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MRVI's Return on Equity is forecast to be low in 3 years time (2.4%).